Optune: Tumor Treating Fields for Glioblastoma

Optune is a wearable portable FDA approved device to treat a type of brain cancer called glioblastoma.

How does optune work?

GBM cancer cells divide quickly, creating more and more cancerous cells that form a mass, or tumor

When Optune is turned on, it creates low-intensity, wave-like electric fields called Tumor Treating Fields, or TTFields. These TTFields are delivered by transducer arrays to the location of a GBM tumor
TTFields interfere with GBM cancer cell division. This action slows or stops GBM cancer cells from dividing, and may destroy them

How does Optune treat where the GBM tumor is located?

Optune has been shown in clinical studies to safely deliver TTFields to the location of a GBM tumor
Optune uses 4 adhesive patches, called tranducer arrays, to deliver TTFields to the location of a GBM tumor. These transducer arrays are applied to your scalp and are connected to the device and battery

Optune® delivers TTFields to the location of a GBM tumor

Optune delivers TTFields to
the location of your GBM tumor
and has not been shown to
affect cells in other parts of the body.

Drugs, like chemotherapy, travel through the bloodstream, affecting cells all over the body

Drugs, like chemotherapy,
travel through the bloodstream,
affecting cells all over the body.

Courtesy of Optune.

Optune Videos

© 2017-2018 Memorial Radiation Oncology Medical Group. All rights reserved.